Putnam Investments LLC Tg Therapeutics, Inc. Transaction History
Putnam Investments LLC
- $73 Billion
- Q4 2023
A detailed history of Putnam Investments LLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Putnam Investments LLC holds 41,401 shares of TGTX stock, worth $1.34 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
41,401
Previous 34,011
21.73%
Holding current value
$1.34 Million
Previous $284,000
148.94%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding TGTX
# of Institutions
338Shares Held
87.7MCall Options Held
2.35MPut Options Held
1.7M-
Vanguard Group Inc Valley Forge, PA15.4MShares$496 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$367 Million0.0% of portfolio
-
State Street Corp Boston, MA9.09MShares$293 Million0.01% of portfolio
-
Pictet Asset Management Holding Sa Carouge, V83.58MShares$116 Million0.1% of portfolio
-
Geode Capital Management, LLC Boston, MA3.21MShares$103 Million0.01% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $4.69B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...